WO1997032539A1 - Device for conveying treated air to the respiratory system of an animal - Google Patents
Device for conveying treated air to the respiratory system of an animal Download PDFInfo
- Publication number
- WO1997032539A1 WO1997032539A1 PCT/IE1997/000014 IE9700014W WO9732539A1 WO 1997032539 A1 WO1997032539 A1 WO 1997032539A1 IE 9700014 W IE9700014 W IE 9700014W WO 9732539 A1 WO9732539 A1 WO 9732539A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- animal
- air
- insert
- nasal cavity
- tubes
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 53
- 210000002345 respiratory system Anatomy 0.000 title claims abstract description 9
- 210000003928 nasal cavity Anatomy 0.000 claims abstract description 33
- 238000011282 treatment Methods 0.000 claims abstract description 18
- 239000003814 drug Substances 0.000 claims abstract description 14
- 210000003128 head Anatomy 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 9
- 239000011148 porous material Substances 0.000 claims description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 2
- 239000000428 dust Substances 0.000 abstract description 6
- 239000000356 contaminant Substances 0.000 abstract description 3
- 210000001331 nose Anatomy 0.000 description 10
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 230000000774 hypoallergenic effect Effects 0.000 description 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
- 229920002334 Spandex Polymers 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000004759 spandex Substances 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000013572 airborne allergen Substances 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 229920002457 flexible plastic Polymers 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
- A61D7/04—Devices for anaesthetising animals by gases or vapours; Inhaling devices
Definitions
- This invention relates to a device for conveying treated air to the respiratory system of an animal, in particular to a device which can be inserted into the nasal cavity of the animal, especially a horse.
- the air which is inhaled by animals contains dust and is contaminated and this may affect the health of the animal. This is of particular relevance to performing animals who undergo considerable physical exertion and these animals are prone to undesirable side effects if exposed to high levels of contaminants. Conditions such as chronic obstructive pulmonary disease (COPD) and similar respiratory disorders have been attributed to the dust levels in the air. Various air-borne allergens have also been implicated as causative agents of COPD. Therefore a serious problem exists if the air being inhaled by the animal is not sufficiently pure.
- COPD chronic obstructive pulmonary disease
- Irish Patent No. S64173 proposes an apparatus for reducing dust levels in a housing unit for an animal.
- a stream of filtered air is constantly supplied to the animal for inhalation, and any dust created within the unit is excluded from the region in which the animal typically breathes.
- This apparatus is relatively costly and regular maintenance of the system is necessary and expensive.
- An apparatus is sought which is cheaper , more flexible and which is not confined to the housing unit.
- the invention provides a device for conveying treated air to the respiratory system of an animal, said device comprising a nasal cavity insert, means for retaining the insert in the nasal cavity, and a treatment unit, in communication with the insert, through which air is inhaled.
- treated air includes air which has been filtered or air which has been exposed to and acts as a carrier of a medicament as hereinafter described.
- the device according to the invention can be worn by the animal for extended periods of time, even when the animal is exercising. Although in practice, the device would generally be removed from a stabled animal when the animal is exercised. Thus, the device could be worn for twenty three out of twenty four hours in any one day.
- the animal is a horse, more especially a thoroughbred.
- the nasal cavity insert is a tube-like structure.
- the tube-like structure is preferably manufactured using a material which is non-allergenic so as to avoid the possibility of any allergic reactions when the tube-like structure is placed in the nasal cavity.
- a plastics pipe manufactured from a material such as polyvinyl chloride (PVC) is suitable.
- the insert is in communication with means for release of expired air, such as a one-way valve.
- a one-way valve provides an easy escape for the air expired by the animal and prevents most of the exhaled air from passing back through the entire length of the insert and through the treatment unit, thereby, possibly contaminating said unit.
- the means for retaining the insert in the nasal cavity is an inflatable cuff or a barb.
- the cuff or barb acts like an anchor retaining the tube in position in the nasal cavity.
- a hypo-allergenic rubber or plastics barb is suitably used.
- an inflatable cuff made from a material which is hypo-allergenic and capable of being inflated, such as a flexible plastics material, is more adaptable and is therefore preferred.
- the cuff is in the uninflated state when inserted into the nasal cavity and can be inflated by using a syringe or an air pump. When fully inflated the cuff provides good retention in the nasal cavity.
- the barb or cuff is bonded onto the insert using a hypo-allergenic adhesive material.
- the means for retaining the insert in the nasal cavity may further comprise a nose band.
- the nose band may suitably comprise a generally U-shaped plastics or elastic member which extends from one nasal cavity to the other nasal cavity over the top of the horse's nose such that the insert is secured intermediate the nose and the nose band.
- the nose band is clamped in both nasal cavities to ensure that the device remains in position if the horse moves vigorously.
- means are provided for preventing exhalation through the treatment unit, such as a non-return valve.
- This valve ensures that no exhaled air from the animal passes through the treatment unit, as such air would possibly be contaminated and this could affect the correct functioning of the unit.
- This valve provides a back-up system for the one-way valve when such is present in the device.
- the device further comprises a safety valve for restoring normal breathing in the event of a blockage in the device. If a filter becomes blocked or a problem arises with the inhalation or exhalation of air through the device, this safety valve provides a path through which the animal can breathe.
- the treatment unit is a filter.
- the filter can contain a medicament, for example, a medicament can be incorporated in the filter by impregnation.
- a medicament is preferably in the form of a powder of a density which can flow in a stream of air passing therethrough or, alternatively, in a form which vaporises in a stream of air.
- a filter is adequate.
- the process of filtering the air provides the animal with air which is free from dust and other particles which might be present in the air and to which the animal may be allergic or which may provoke unfavourable reactions.
- the primary purpose of the device may be to administer a medicament to the animal.
- the treatment unit can comprise a cartridge or other support for the medicament which is again conveyed to the nasal cavity of the animal on inhalation of air.
- air inhaled by the animal can be treated by filtering and/or medicating the air.
- medicaments examples include antibiotics, antihistamines, anti-inflammatory agents, anti-asthmatic agents and an'i ungal agents.
- the nasal insert can act as a carrier for a medicament which enters the bloodstream transmucosally.
- the average pore size of the filter is suitably in the range 0.05 ⁇ m to lO ⁇ m, and preferably in the range 0.1 ⁇ m to l.O ⁇ m.
- the device is held in position by a flexible material which covers the animal's head, an example of such a material being the elasticated fabric known as "Lycra” ("Lycra" is a trade mark).
- a harness is used to keep the device in place on the animal.
- the device comprises two inflatable cuffs, each of which can be positioned in a nasal cavity of the animal.
- each cuff holds a tube in position and each tube leads to a separate treatment unit.
- Fig. 1 is a perspective view of a device according to the invention
- Fig. 2 is a side view of a horse's head showing the device of Fig. 1 in place;
- Fig. 3 is a front view of a horse's head showing the device of Fig. 1 in place.
- a device for conveying treated air to the respiratory system of a horse comprising two filters 11 each of which is attached to a tube 12 at one end 13 thereof.
- the other end 14 of either tube 12 can be inserted into a nasal cavity 15 of the horse (see Figs. 2 and 3).
- the two tubes 12 are joined together along a portion of their length intermediate their ends 13 and 14.
- the ends 14 of the tubes 12 define nasal inserts.
- An inflatable cuff 16 is attached proximal to the end 14 of each tube 12. The cuffs 16 are in the uninflated state when inserted into the nasal cavities 15.
- the cuffs 16 are then inflated, for example, by inserting a syringe (not shown) into a valve 17 and injecting air to inflate each of the cuffs 16.
- the cuffs 16 in their inflated state retain the tubes 12 in the nasal cavities 15.
- a groove is provided in the surface of the cuffs 16 in the inflated state to allow ducting of any tears through the horse's nasal tear duct when the device is in position in the nasal cavities 15.
- Air which is inhaled by the animal is drawn through the filters 11 via the tubes 12 into the respiratory system and conveyed directly to the lungs of the animal. The animal thus inhales air which has been treated and, therefore, one has complete control over the air being inhaled by the animal with this device.
- one-way valves 18 allow the exhaled air to pass out of the tubes 12, and prevent most of the exhaled air from passing back through the entire length of the tubes 12, as this contaminated air could possibly interfere with the filters 11.
- a non- return valve 19 is positioned in each tube 12 close to the filter 11. The valves 19 guarantee that the filters 11 are free from any contaminants or dirt which the animal may exhale.
- Further safety valves 20 (only one shown in Fig. 1) are attached to the tubes 12 downstream of the one-way valves 18.
- valves 20 provide a back-up to the device 10 in the event that air cannot be expired through the valves 18 due to a mechanical failure in their operation or in the event that the filters 11 become blocked.
- the safety valves 20 ensure that the animal will still be able to breathe in the event that the passage of air through the device 10 is impeded in any way.
- the device 10 is shown in place on a horse 21.
- the inflatable cuffs 16 (see Fig. 1) are then inflated to maintain the tubes 12 in place in the nasal cavities 15.
- the two filters 11 are placed at the back of the head 22.
- Each filter 11 is connected to a tube 12 which passes over the head between the ears 23.
- the tubes 12 pass along the front of the head and enter the nasal cavities 15.
- a nose band 24 comprising a resilient U-shaped plastics member is clamped in both nasal cavities 15 and extends over the top of the horse's nose such that the tubes 12 are secured intermediate the nose and the nose band 24.
- FIG. 3 the front view of the horse's head shows that the tubes 12 join together at the front.
- the device 10 as illustrated comprises a circular tube 12 however, this tube 12 could also have a semi -circular shape, for ease of attachment to the horse and for ease of use.
- the device 10 could also be held in position by a harness or a flexible material which covers the animal's head without obstructing the horse's vision.
- the device 10 may comprise a single filter attached to a single tube which splits into two tubes (one of which enters each nasal cavity). This would provide a lighter and less bulky device, if required, when in place on the animal.
- the tubes 12 then part and enter the nasal cavities 15.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Respiratory Apparatuses And Protective Means (AREA)
Abstract
A device (10) for conveying treated air to the respiratory system of an animal, for example a thoroughbred horse, comprises a pair of tubes (12) joined together along a portion of their lengths. An end (14) of each tube (12) is inserted into a nasal cavity of the animal. An inflatable cuff (16) is provided proximal to the end (14) of each tube (12), and when inflated within the nasal cavity the cuffs (16) hold the tubes (12) in position such that the animal receives air via the tubes (12). A treatment unit (11) is attached to the other end (13) of each tube (12), such that air inhaled by the animal is drawn through the treatment units (11) via the tubes (12) into the air passages of the animal. The treatment units (11) may filter the inhaled air to remove dust and other contaminants or they may impregnate the air with a medicament. A set of valves (18, 19, 20) ensures that no exhaled air passes through the treatment unit (11) and that the animal can breathe safely in the event of a blockage or if the passage of air through the device (10) is impeded in any way. The device (10) can be worn for extended periods of time, even when the animal is exercising.
Description
Device for conveying treated air to the respiratory system of an animal
This invention relates to a device for conveying treated air to the respiratory system of an animal, in particular to a device which can be inserted into the nasal cavity of the animal, especially a horse.
In general, the air which is inhaled by animals contains dust and is contaminated and this may affect the health of the animal. This is of particular relevance to performing animals who undergo considerable physical exertion and these animals are prone to undesirable side effects if exposed to high levels of contaminants. Conditions such as chronic obstructive pulmonary disease (COPD) and similar respiratory disorders have been attributed to the dust levels in the air. Various air-borne allergens have also been implicated as causative agents of COPD. Therefore a serious problem exists if the air being inhaled by the animal is not sufficiently pure.
Irish Patent No. S64173 proposes an apparatus for reducing dust levels in a housing unit for an animal. A stream of filtered air is constantly supplied to the animal for inhalation, and any dust created within the unit is excluded from the region in which the animal typically breathes. This apparatus is relatively costly and regular maintenance of the system is necessary and expensive. An apparatus is sought which is cheaper , more flexible and which is not confined to the housing unit.
A further problem encountered by many veterinary surgeons and other people dealing with performing animals, is the difficulty of administering medicaments to these animals, particularly on a continuous or repeated basis.
In the case of conditions or diseases involving the respiratory system treatments of the type used in the case of humans, such as the use of an oxygen tent, are not practical in the case of animals. The horse and other animals are not amenable to the use of a gas mask in the conscious state. Thus, other devices and means of treatment
must be devised. For example, drugs such as antibiotics are occasionally administered intranasally by the use of tubes which convey the drug from a receptable to the nasal passages under supervision, normally involving a veterinary surgeon.
An apparatus which would allow for the continuous administration of treated (e.g. dust-free or medicament-carrying) air without constant supervision would be a distinct advantage.
Thus, the invention provides a device for conveying treated air to the respiratory system of an animal, said device comprising a nasal cavity insert, means for retaining the insert in the nasal cavity, and a treatment unit, in communication with the insert, through which air is inhaled.
The term "treated air" as used herein includes air which has been filtered or air which has been exposed to and acts as a carrier of a medicament as hereinafter described.
The device according to the invention can be worn by the animal for extended periods of time, even when the animal is exercising. Although in practice, the device would generally be removed from a stabled animal when the animal is exercised. Thus, the device could be worn for twenty three out of twenty four hours in any one day.
Suitably, the animal is a horse, more especially a thoroughbred.
Preferably, the nasal cavity insert is a tube-like structure. The tube-like structure is preferably manufactured using a material which is non-allergenic so as to avoid the possibility of any allergic reactions when the tube-like structure is placed in the nasal cavity. A plastics pipe manufactured from a material such as polyvinyl chloride (PVC) is suitable.
Preferably, the insert is in communication with means for release of expired air, such as a one-way valve. This type of valve provides an
easy escape for the air expired by the animal and prevents most of the exhaled air from passing back through the entire length of the insert and through the treatment unit, thereby, possibly contaminating said unit.
Preferably, the means for retaining the insert in the nasal cavity is an inflatable cuff or a barb. The cuff or barb acts like an anchor retaining the tube in position in the nasal cavity. A hypo-allergenic rubber or plastics barb is suitably used. However, an inflatable cuff made from a material which is hypo-allergenic and capable of being inflated, such as a flexible plastics material, is more adaptable and is therefore preferred. The cuff is in the uninflated state when inserted into the nasal cavity and can be inflated by using a syringe or an air pump. When fully inflated the cuff provides good retention in the nasal cavity. The barb or cuff is bonded onto the insert using a hypo-allergenic adhesive material. The anatomy of a horse's nasal cavity is particularly suited to holding an inflated cuff, even when the horse is undergoing strenuous exercise. If required, the means for retaining the insert in the nasal cavity may further comprise a nose band. The nose band may suitably comprise a generally U-shaped plastics or elastic member which extends from one nasal cavity to the other nasal cavity over the top of the horse's nose such that the insert is secured intermediate the nose and the nose band. The nose band is clamped in both nasal cavities to ensure that the device remains in position if the horse moves vigorously.
Further, preferably, means are provided for preventing exhalation through the treatment unit, such as a non-return valve. This valve ensures that no exhaled air from the animal passes through the treatment unit, as such air would possibly be contaminated and this could affect the correct functioning of the unit. This valve provides a back-up system for the one-way valve when such is present in the device.
Preferably, the device further comprises a safety valve for restoring normal breathing in the event of a blockage in the device. If a filter becomes blocked or a problem arises with the inhalation or exhalation of air through the device, this safety valve provides a path through which the animal can breathe.
Further, preferably, the treatment unit is a filter.
The filter can contain a medicament, for example, a medicament can be incorporated in the filter by impregnation. Such a medicament is preferably in the form of a powder of a density which can flow in a stream of air passing therethrough or, alternatively, in a form which vaporises in a stream of air.
If the device is required to clean the air being inhaled by the animal, a filter is adequate. The process of filtering the air provides the animal with air which is free from dust and other particles which might be present in the air and to which the animal may be allergic or which may provoke unfavourable reactions.
Alternatively, the primary purpose of the device may be to administer a medicament to the animal. In this situation, the treatment unit can comprise a cartridge or other support for the medicament which is again conveyed to the nasal cavity of the animal on inhalation of air.
In this way, air inhaled by the animal can be treated by filtering and/or medicating the air.
Examples of such medicaments are antibiotics, antihistamines, anti-inflammatory agents, anti-asthmatic agents and an'i ungal agents.
Indeed, the nasal insert can act as a carrier for a medicament which enters the bloodstream transmucosally.
The average pore size of the filter is suitably in the range 0.05μm to lOμm, and preferably in the range 0.1 μm to l.Oμm.
Further preferably, the device is held in position by a flexible material which covers the animal's head, an example of such a material being the elasticated fabric known as "Lycra" ("Lycra" is a trade mark).
Alternatively or additionally, a harness is used to keep the device in place on the animal.
According to a preferred embodiment, the device comprises two inflatable cuffs, each of which can be positioned in a nasal cavity of the animal. With this embodiment, each cuff holds a tube in position and each tube leads to a separate treatment unit.
The invention will be further illustrated by the following description of an embodiment thereof, given by way of example only with reference to the accompanying drawings, in which:
Fig. 1 is a perspective view of a device according to the invention;
Fig. 2 is a side view of a horse's head showing the device of Fig. 1 in place; and
Fig. 3 is a front view of a horse's head showing the device of Fig. 1 in place.
In Fig. 1 there is indicated, generally at 10, a device according to the invention for conveying treated air to the respiratory system of a horse comprising two filters 11 each of which is attached to a tube 12 at one end 13 thereof. The other end 14 of either tube 12 can be inserted into a nasal cavity 15 of the horse (see Figs. 2 and 3). The two tubes 12 are joined together along a portion of their length intermediate their ends 13 and 14. The ends 14 of the tubes 12 define nasal inserts. An inflatable cuff 16 is attached proximal to the end 14 of each tube 12. The cuffs 16 are in the uninflated state when inserted into the nasal cavities 15. The cuffs 16 are then inflated, for example, by inserting a syringe (not shown) into a valve 17 and injecting air to inflate each of the cuffs 16. The cuffs 16 in their inflated state retain the tubes 12 in the nasal cavities 15. A groove is provided in the surface of the cuffs 16 in the inflated state to allow ducting of any tears through the horse's nasal tear duct when the device is in position in the nasal cavities 15.
Air which is inhaled by the animal is drawn through the filters 11 via the tubes 12 into the respiratory system and conveyed directly to the lungs of the animal. The animal thus inhales air which has been treated and, therefore, one has complete control over the air being inhaled by the animal with this device. When the air is exhaled by the animal, one-way valves 18 allow the exhaled air to pass out of the tubes 12, and prevent most of the exhaled air from passing back through the entire length of the tubes 12, as this contaminated air could possibly interfere with the filters 11. To ensure that no exhaled air reaches the filters 11 , a non- return valve 19 is positioned in each tube 12 close to the filter 11. The valves 19 guarantee that the filters 11 are free from any contaminants or dirt which the animal may exhale. Further safety valves 20 (only one shown in Fig. 1) are attached to the tubes 12 downstream of the one-way valves 18. These valves 20 provide a back-up to the device 10 in the event that air cannot be expired through the valves 18 due to a mechanical failure in their operation or in the event that the filters 11 become blocked. Thus, the safety valves 20 ensure that the animal will still be able to breathe in the event that the passage of air through the device 10 is impeded in any way.
Referring additionally to Figs. 2 and 3, the device 10 is shown in place on a horse 21. When the tubes 12 are inserted into the nasal cavities 15 of the horse 21 , the inflatable cuffs 16 (see Fig. 1) are then inflated to maintain the tubes 12 in place in the nasal cavities 15. The two filters 11 are placed at the back of the head 22. Each filter 11 is connected to a tube 12 which passes over the head between the ears 23. The tubes 12 pass along the front of the head and enter the nasal cavities 15. A nose band 24 comprising a resilient U-shaped plastics member is clamped in both nasal cavities 15 and extends over the top of the horse's nose such that the tubes 12 are secured intermediate the nose and the nose band 24. This ensures that the tubes 12 are held in position in the nasal cavities 15 of the horse 21, even if the horse moves its head vigorously. In Fig. 3 the front view of the horse's head shows that the tubes 12 join together at the front.
The device 10 as illustrated comprises a circular tube 12 however, this tube 12 could also have a semi -circular shape, for ease of attachment to the horse and for ease of use.
The device 10 could also be held in position by a harness or a flexible material which covers the animal's head without obstructing the horse's vision.
It is also possible for the device 10 to comprise a single filter attached to a single tube which splits into two tubes (one of which enters each nasal cavity). This would provide a lighter and less bulky device, if required, when in place on the animal. The tubes 12 then part and enter the nasal cavities 15.
Claims
1. A device for conveying treated air to the respiratory system of an animal, said device comprising a nasal cavity insert, means for retaining the insert in the nasal cavity, and a treatment unit, in communication with the insert, through which air is inhaled.
2. A device according to Claim 1, wherein the animal is a horse.
3. A device according to Claim 1 or 2, wherein the insert is a tube-like structure.
4. A device according to any preceding claim, wherein the insert is in communication with means for release of expired air.
5. A device according to Claim 4, wherein the means for release of expired air is a one-way valve.
6. A device according to any preceding claim, wherein the means for retaining the insert in the nasal cavity is an inflatable cuff.
7. A device according to any one of Claims 1-5, wherein the means for retaining the insert in the nasal cavity is a barb.
8. A device according to any preceding claim, wherein means are provided for preventing exhalation through the treatment unit.
9. A device according to Claim 8, wherein the means for preventing exhalation through the treatment unit is a non-return valve.
10. A device according to any preceding claim, further comprising a safety valve for restoring normal breathing in the event of a blockage in the device.
11. A device according to any preceding claim, wherein the treatment unit is a filter.
12. A device according to Claim 11, wherein the filter contains a medicament.
13. A device according to Claim 11 or 12, wherein the filter has an average pore size in the range 0.05μm to lOμm.
14. A device according to Claims 11 or 12, wherein the filter has an average pore size in the range of 0.1 μm to l.Oμm.
15. A device according to any one of Claims 1 -10, wherein the treatment unit is a cartridge which contains a medicament.
16. A device according to any preceding claim, which is held in position by a flexible material which covers the animal's head.
17. A device according to any one of Claims 1-15, which is held in position by a harness.
18. A device substantially as hereinbefore described with particular reference to and as illustrated in the accompanying drawings.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU22278/97A AU2227897A (en) | 1996-03-04 | 1997-03-03 | Device for conveying treated air to the respiratory system of an animal |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IES960199 IES73224B2 (en) | 1996-03-04 | 1996-03-04 | Device for conveying treated air to an animal |
IES960199 | 1996-03-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997032539A1 true WO1997032539A1 (en) | 1997-09-12 |
Family
ID=11041099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IE1997/000014 WO1997032539A1 (en) | 1996-03-04 | 1997-03-03 | Device for conveying treated air to the respiratory system of an animal |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2227897A (en) |
IE (1) | IES73224B2 (en) |
WO (1) | WO1997032539A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2378393A (en) * | 2001-06-12 | 2003-02-12 | Optinose As | Nasal delivery devices |
GB2405800A (en) * | 2001-06-12 | 2005-03-16 | Optinose As | Nasal delivery devices |
GB2414414A (en) * | 2001-06-12 | 2005-11-30 | Optinose As | Nasal delivery devices |
WO2007002979A1 (en) * | 2005-07-01 | 2007-01-11 | Robair Wartan Dallal | Advanced mask air filter |
WO2018137032A1 (en) * | 2017-01-27 | 2018-08-02 | Vet Tech Innovations Ltd. | Equine respiratory prosthetic device and methods of use |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR648907A (en) * | 1928-01-16 | 1928-12-15 | Heat exchanger inhaler device | |
DE1566301A1 (en) * | 1967-11-17 | 1970-07-23 | Medizintechnik Leipzig Veb | Anesthetic mask for animals, especially small animals |
EP0444905A1 (en) * | 1990-02-27 | 1991-09-04 | Minnesota Mining And Manufacturing Company | Equine aerosol drug delivery method and apparatus |
EP0537991A2 (en) * | 1991-10-15 | 1993-04-21 | Canadian Monaghan Limited | Equine mask |
-
1996
- 1996-03-04 IE IES960199 patent/IES73224B2/en not_active IP Right Cessation
-
1997
- 1997-03-03 WO PCT/IE1997/000014 patent/WO1997032539A1/en active Application Filing
- 1997-03-03 AU AU22278/97A patent/AU2227897A/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR648907A (en) * | 1928-01-16 | 1928-12-15 | Heat exchanger inhaler device | |
DE1566301A1 (en) * | 1967-11-17 | 1970-07-23 | Medizintechnik Leipzig Veb | Anesthetic mask for animals, especially small animals |
EP0444905A1 (en) * | 1990-02-27 | 1991-09-04 | Minnesota Mining And Manufacturing Company | Equine aerosol drug delivery method and apparatus |
EP0537991A2 (en) * | 1991-10-15 | 1993-04-21 | Canadian Monaghan Limited | Equine mask |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2378393A (en) * | 2001-06-12 | 2003-02-12 | Optinose As | Nasal delivery devices |
GB2378393B (en) * | 2001-06-12 | 2004-01-14 | Optinose As | Nasal devices |
GB2405800A (en) * | 2001-06-12 | 2005-03-16 | Optinose As | Nasal delivery devices |
GB2414414A (en) * | 2001-06-12 | 2005-11-30 | Optinose As | Nasal delivery devices |
GB2405800B (en) * | 2001-06-12 | 2006-02-22 | Optinose As | Nasal devices |
GB2414414B (en) * | 2001-06-12 | 2006-03-22 | Optinose As | Nasal devices |
CN100428966C (en) * | 2001-06-12 | 2008-10-29 | 奥普蒂诺斯公司 | nasal device |
US7975690B2 (en) | 2001-06-12 | 2011-07-12 | Optinose As | Nasal devices |
US9205208B2 (en) | 2001-06-12 | 2015-12-08 | Optinose As | Nasal devices |
WO2007002979A1 (en) * | 2005-07-01 | 2007-01-11 | Robair Wartan Dallal | Advanced mask air filter |
WO2018137032A1 (en) * | 2017-01-27 | 2018-08-02 | Vet Tech Innovations Ltd. | Equine respiratory prosthetic device and methods of use |
US11331177B2 (en) | 2017-01-27 | 2022-05-17 | Vet Tech Innovations Ltd | Equine respiratory prosthetic device and methods of use |
Also Published As
Publication number | Publication date |
---|---|
IES73224B2 (en) | 1997-05-21 |
AU2227897A (en) | 1997-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2364183C (en) | Nasal ventilation interface | |
US6994089B2 (en) | Nasal ventilation interface | |
JP7200209B2 (en) | ventilation mask | |
US6776162B2 (en) | Ventilation interface for sleep apnea therapy | |
US9919121B2 (en) | Ventilation interface for sleep apnea therapy | |
US4406283A (en) | Oxygen cannulae for continuous administration of oxygen, and its associated mounting structure and method for mounting same onto the head of a patient | |
US7866320B2 (en) | Nasal canula and mouthpiece assembly and method | |
EP0088761A4 (en) | Device for treating snoring sickness. | |
KR100897161B1 (en) | Intranasal Implant Respiratory Mask | |
JP7689538B2 (en) | Masks and their systems | |
ATE83939T1 (en) | BREATHING DEVICE. | |
US20240299691A1 (en) | Tube and/or patient interface for delivery of gas | |
KR102363553B1 (en) | Oxygen mask guard | |
WO1997032539A1 (en) | Device for conveying treated air to the respiratory system of an animal | |
US20080314391A1 (en) | Portable "cleaned, decontaminated and disinfected air" breathing device | |
US20100170514A1 (en) | Air filter for a mask assembly | |
EP1317941B1 (en) | Nasal ventilation cannula | |
WO1999043389A1 (en) | Animal exposure masks | |
CN112402762A (en) | Be arranged in paediatrics medical treatment neonate to breathe auxiliary device | |
WO2003105938A1 (en) | A device for the exchange of heat and moisture between inhalation and exhalation air flows | |
KR102316855B1 (en) | Nose breathing apparatus | |
AU782824B2 (en) | Nasal ventilation interface | |
CA2416410C (en) | Ventilation interface for sleep apnea therapy | |
TW200427480A (en) | Wearable respirator produced medicament | |
WO2021256998A1 (en) | A face mask |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA CN CZ HU IL JP MX NO NZ PL RU US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 97531628 Format of ref document f/p: F |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
122 | Ep: pct application non-entry in european phase |